Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.77 |
| ▸ | RAB9A | P51151 | 7/20 | 0.69 |
| ▸ | NPC1 | O15118 | 5/20 | 0.65 |
| ▸ | MAPT | P10636 | 4/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.61 |
| ▸ | TP53 | P04637 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 4/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | GPR17 | Q13304 | 1/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | ABL1 | P00519 | 1/20 | 0.56 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL983433 | 0.87 | ALDH1A1 (1.00) | ALDH1A1RAB9ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL7975430 | 0.87 | ALDH1A1 (0.72) | ALDH1A1RAB9ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL307662 | 0.85 | ALDH1A1 (0.56) | ALDH1A1RAB9ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL863169 | 0.84 | RAB9A (0.71) | ALDH1A1RAB9ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL11654124 | 0.84 | RAB9A (0.71) | ALDH1A1RAB9ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL8123409 | 0.84 | KMT2A (0.68) | ALDH1A1RAB9ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL27453091 | 0.84 | ALDH1A1 (0.56) | ALDH1A1RAB9ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL4795890 | 0.84 | KMT2A (0.66) | ALDH1A1RAB9ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL6242208 | 0.83 | RAB9A (0.84) | ALDH1A1RAB9ANPC1MAPTSMN1; SMN2 | |
| SCHEMBL2138281 | 0.82 | ALDH1A1 (0.66) | ALDH1A1RAB9ANPC1MAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250382303-A1 | NOVEL COMPOUND AS NADPH OXIDASE 2 INHIBITOR AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2025-12-18 | — | — | US | disclosed |
| EP-4549441-A1 | NOVEL COMPOUND AS NADPH OXIDASE 2 INHIBITOR AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | Dongguk University Industry-Academic Cooperation Foundation (KR) | 2025-05-07 | — | — | EP | disclosed |
| US-12060362-B2 | Inhibitors of glucose transporters (GLUTs) | LEAD DISCOVERY CENTER GMBH (DE) | 2024-08-13 | — | — | US | disclosed |
| WO-2024005526-A1 | NOVEL COMPOUND AS NADPH OXIDASE 2 INHIBITOR AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | 동국대학교 산학협력단 | 2024-01-04 | — | — | WO | disclosed |
| WO-2024005506-A1 | NOVEL COMPOUND WITH INHIBITORY ACTIVITY AGAINST NADPH OXIDASE 2 (NOX2) AND USE THEREOF | 동국대학교 산학협력단 | 2024-01-04 | — | — | WO | disclosed |
| EP-3814359-B1 | INHIBITORS OF GLUCOSE TRANSPORTERS (GLUTS) | LEAD DISCOVERY CENTER GMBH (DE) | 2022-08-17 | — | — | EP | disclosed |
| US-20210198269-A1 | INHIBITORS OF GLUCOSE TRANSPORTERS (GLUTs) | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2021-07-01 | — | — | US | disclosed |
| US-20210198269-A1 | INHIBITORS OF GLUCOSE TRANSPORTERS (GLUTs) | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2021-07-01 | — | — | US | disclosed |
| EP-3814359-A1 | INHIBITORS OF GLUCOSE TRANSPORTERS (GLUTS) | Lead Discovery Center GmbH (DE) | 2021-05-05 | — | — | EP | disclosed |
| WO-2018045969-A1 | COMPOUND FOR ACTIVATING ADENOSINE MONOPHOSPHATE-ACTIVATED PROTEIN KINASE | 法玛科技顾问股份有限公司 | 2018-03-15 | — | — | WO | disclosed |
| US-20100041645-A1 | RHO KINASE INHIBITORS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-02-18 | — | — | US | disclosed |
| US-20100041645-A1 | RHO KINASE INHIBITORS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-02-18 | — | — | US | disclosed |
| EP-2114869-A1 | RHO KINASE INHIBITORS | Boehringer Ingelheim International GmbH (DE) | 2009-11-11 | — | — | EP | disclosed |
| WO-2008086047-A1 | RHO KINASE INHIBITORS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-07-17 | — | — | WO | disclosed |
| WO-2008086047-A1 | RHO KINASE INHIBITORS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-07-17 | — | — | WO | disclosed |
| CN-1130351-C | 1,5-benzodiazepine derivatives | ZERIA PHARM CO LTD (JP) | 2003-12-10 | — | — | CN | disclosed |
| EP-0628033-B1 | BENZODIAZEPIN DERIVATIVES USEFUL AS CCK-RECEPTOR ANTAGONISTS | YAMANOUCHI PHARMA CO LTD (JP) | 2003-07-23 | — | — | EP | disclosed |
| CN-1246850-A | 1,5-benzodiazepine derivatives | ZERIA PHARM CO LTD (JP) | 2000-03-08 | — | — | CN | disclosed |
| EP-0628033-A1 | BENZODIAZEPIN DERIVATIVES USEFUL AS CCK-RECEPTOR ANTAGONISTS | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1994-12-14 | — | — | EP | disclosed |
| CN-1075717-A | Benzodiazepine * derivatives | YAMANOUCHI PHARMA CO LTD (JP) | 1993-09-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12060362-B2 | Inhibitors of glucose transporters (GLUTs) | SLC2A1, SLC2A3, SLC2A4 | ALDH1A1 364/4885RAB9A 3217/4885NPC1 549/4885 |
| US-20100041645-A1 | RHO KINASE INHIBITORS | CIT, ROCK1, RHOT2 | ALDH1A1 3661/4885RAB9A 214/4885NPC1 3330/4885 |
| US-20210198269-A1 | INHIBITORS OF GLUCOSE TRANSPORTERS (GLUTs) | SLC2A1, SLC2A3, SLC2A4 | ALDH1A1 515/4885RAB9A 3223/4885NPC1 555/4885 |
| US-20250382303-A1 | NOVEL COMPOUND AS NADPH OXIDASE 2 INHIBITOR AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | CYBB, NOX4, NOX1 | ALDH1A1 565/4885RAB9A 2808/4885NPC1 2281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.